홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
RGNX
#2557
REGENXBIO Inc.
9.040
0
+8.00%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+8.00%
월간 변동
-5.88%
6달 변화
-32.69%
년간 변동율
-32.69%
이전 종가
8.370
0
Open
9.040
0
Bid
Ask
Low
9.040
0
High
9.040
0
양
78
마켓
주식
헬스케어
RGNX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
42.5 M
42.95 M
43.46 M
44.43 M
50.09 M
—
Valuation ratios
Enterprise value
1.59 B
1.06 B
870.11 M
780.28 M
329.64 M
1.32 B
Price to earnings ratio
-15.22
11.24
-3.42
-3.05
-1.68
-9.2
Price to sales ratio
10.94
3.05
8.52
8.89
4.89
12.97
Price to cash flow ratio
31.28
6.56
4.63
3.67
2.21
14.07
Price to book ratio
4.48
1.88
1.86
2.57
1.47
2.72
Enterprise value to EBITDA ratio
41.99
3.3
-19.46
-13.65
-5.56
—
Profitability ratios
Return on assets %
0.16
0.11
0.34
0.46
0.49
0.36
Return on equity %
0.29
0.17
0.54
0.85
0.87
0.93
Return on invested capital %
226.49
126.79
177.57
257.21
402.58
—
Gross margin %
71.91
88.43
51.61
58.76
50.76
346.65
Operating margin %
77.14
34.01
233.2
297.12
297.91
728.3
EBITDA margin %
24.49
68.28
-39.67
-63.37
-75.71
—
Net margin %
71.98
27.18
248.68
291.99
289.94
788.25
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.52
3.98
3.19
2.57
2.69
11.42
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.26
0.52
0.12
0.13
0.15
0.32
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.45
4.98
4.81
4.99
3.5
2.03
EBIT per share
1.04
7.45
-0.93
-1.29
-1.11
—
EBITDA per share
1.02
7.31
-1.04
-1.31
-1.2
—
Total debt per share
—
—
—
—
—
—
Cash per share
14.02
19.34
13.1
7.18
4.95
23.15
Net current asset value per share
14.25
11.81
9.64
7.66
5.62
25.39
Tangible book value per share
10.13
17.4
11.96
7.13
5.24
17.85
Working capital per share
12.06
8.84
6.62
4.68
3.53
16.5
Book value per share
10.13
17.4
11.96
7.13
5.24
17.85
뉴스
유니큐어 주식, FDA 관계자 발언 후 스티펠 논평
Stifel comments on uniQure shares after FDA commissioner remarks
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
REGENXBIO: Cautiously Bullish After FDA Setbacks (NASDAQ:RGNX)
Regenxbio stock price target lowered to $32 at H.C. Wainwright after FDA rejection
Intel, Wells Fargo among market cap stock movers on Tuesday
Netflix and Oracle among market cap stock movers on Tuesday
Regenxbio stock price target lowered by Goldman Sachs on RGX-121 setback
장시간 거래 종목: 온 세미컨덕터, 크레도, 업워크, 리젠엑스바이오 등
REGENXBIO, 헌터증후군 유전자 치료제 FDA 거부 후 급락